Jonathan Drachman
2020 - Aquinox Pharmaceuticals
In 2020, Jonathan Drachman earned a total compensation of $4.5M as Chief Executive Officer at Aquinox Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $219,680 |
|---|---|
| Salary | $418,750 |
| Stock Awards | $3,830,108 |
| Total | $4,468,538 |
Drachman received $3.8M in stock awards, accounting for 86% of the total pay in 2020.
Drachman also received $219.7K in non-equity incentive plan and $418.8K in salary.
Rankings
In 2020, Jonathan Drachman's compensation ranked 2,522nd out of 13,090 executives tracked by ExecPay. In other words, Drachman earned more than 80.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,522 out of 13,090 | 81st |
Division Manufacturing | 966 out of 5,621 | 83rd |
Major group Chemicals And Allied Products | 348 out of 2,254 | 85th |
Industry group Drugs | 299 out of 1,954 | 85th |
Industry Pharmaceutical Preparations | 217 out of 1,459 | 85th |
Source: SEC filing on March 31, 2022.
Drachman's colleagues
We found one more compensation record of an executive who worked with Jonathan Drachman at Aquinox Pharmaceuticals in 2020.
2020
Robert Ho
Aquinox Pharmaceuticals